参考文献/References:
[1]Chen W,He J,Sun K,et al.Cancer incidence and mortality in China,2014[J].Cancer incidence and mortality in China,2014,30(1):1-12.[2]Fan L,Strasser-Weippl K,Li JJ,et al.Breast cancer in China[J].Lancet Oncol,2014,15(7):279-289.[3]陈万青,郑荣寿,曾红梅,等.2011年中国恶性肿瘤发病和死亡分析[J].中国肿瘤,2016,24(1):1-10.[4]Rani P,Pal D,Hegde RR,et al.Acetamides:chemotherapeutic agents for inflammation-associated cancers[J].Journal of Chemotherapy,2016,28(4):255-265.[5]Werb Z,Coussens LM.Inflammation and cancer[M].Springer,2006.[6]Lian L,Xia YY,Zhou C,et al.Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer[J].Cancer Biomarkers,2015,15(6):899-907.[7]Gunaldi M,Goksu S,Erdem D,et al.Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer:A multicenter study[J].International Journal of Clinical and Experimental Medicine,2015,8(4):5937-5942.[8]Zhang H,Xia H,Zhang L,et al.Clinical significance of preoperative neutrophil–lymphocyte vs platelet–lymphocyte ratio in primary operable patients with non–small cell lung cancer[J].The American Journal of Surgery,2015,210(3):S0002961015002901.[9]Sun KY,Xu JB,Chen SL,et al.Novel immunological and nutritional-based prognosticindex for gastric cancer[J].World Journal of Gastroenterology,2015(19):5961-5971.[10]Mousavi Ardehaie R,Hashemzadeh S,Behrouz Sharif S,et al.Aberrant methylated EDNRB can act as a potential diagnostic biomarker in sporadic colorectal cancer while KISS1 is controversial[J].Bioengineered,2017,8(5):555-564.[11]Lee PP,Cereghetti DM.Tumor-Derived Exosomes Contain microRNAs with Immunological Function:Implications for a Novel Immunosuppression Mechanism[J].Microrna,2014,2(3):194-204.[12]Coupland L,Hindmarsh E,Gardiner E,et al.The influence of platelet membranes on tumour cell behaviour[J].Cancer and Metastasis Reviews,2017,36(2):215-224.[13]Chouaib S,Umansky V,Kieda C.The role of hypoxia in shaping the recruitment of proangiogenic and immunosuppressive cells in the tumor microenvironment[J].Contemp Oncol,2018,22(1A):7-13.[14]Nakamura M,Inufusa H,Adachi T,et al.Involvement of galectin-3 expression in colorectal cancer progression and metastasis[J].International Journal of Oncology,1999,15(1):143.[15]Liu C,Yang Z,Deng Z,et al.Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3[J].Iubmb Life,2018,70(6):536.[16]Kut C,Mac Gabhann F,Popel AS.Where is VEGF in the body?A meta-analysis of VEGF distribution in cancer[J].British Journal of Cancer,2007,97(7):978-985.[17]Ruffell B,Denardo DG,Affara NI,et al.Lymphocytes in cancer development:Polarization towards pro-tumor immunity[J].Cytokine&Growth Factor Reviews,2010,21(1):1-10.[18]Hu Z,Xia J,Fan W,et al.Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice[J].Oncotarget,2016,7(6):6448-6459.[19]Xu Q,Wang C,Yuan X,et al.Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Head and Neck Squamous Cell Carcinoma[J].Translational Oncology,2017,10(1):10-16.[20]Liu Y,Li Y,Liu Z,et al.Prognostic significance of matrix metalloproteinase-20 overexpression in laryngeal squamous cell carcinoma[J].Acta Oto-laryngologica,2011,131(7):769-773.[21]Mori H,Kubo M,Yamaguchi R,et al.The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer[J].Oncotarget,2017,8(9):15584-15592.[22]Mao Y,Qu Q,Chen X,et al.The prognostic value of tumorinfiltrating lymphocytes in breast cancer:a systematic review and meta-analysis[J].PLoS One,2016,11(4):e0152500.[23]Wu Y,Li C,Zhao J,et al.Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis[J].World Journal of Surgical Oncology,2016,14(1):289.[24]Graziano V,Grassadonia A,Iezzi L,et al.Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients[J].Breast,2019(44):33-38.[25]Asano Y,Kashiwagi S,Onoda N,et al.Platelet–Lymphocyte Ratio as a Useful Predictor of the Therapeutic Effect of Neoadjuvant Chemotherapy in Breast Cancer[J].PLoS One,2016,11(7):e0153459.[26]Losada B,Guerra JA,Malón D,et al.Pretreatment neutrophil/lymphocyte,platelet/lymphocyte,lymphocyte/monocyte,andneutrophil/monocyte ratios and outcome in elderly breast cancer patients[J].Clinical and Translational Oncology,2019(21):855-863.[27]Krenn-Pilko S,Langsenlehner U,Thurner EM,et al.The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients[J].British Journal of Cancer,2014,110(10):2524-2530.[28]Blanchette PS,Desautels DN,Pond GR,et al.Factors influencing survival among patients with HER2-positive metastatic breast cancer treated with trastuzumab[J].Breast Cancer Research and Treatment,2018(170):169-177. [29]Zhang M,Huang XZ,Song YX,et al.High Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Breast Cancer:A Meta-Analysis[J].BioMed Research International,2017(2017):1-11.[30]Zhu Y,Si W,Sun Q,et al.Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer[J].Oncotarget,2017,8(1):1023-1030.
相似文献/References:
[1]董 云.SPECT/CT 双时相99mTc- MIBI断层显像
在乳腺癌诊断中的应用[J].医学信息,2018,31(05):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
DONG Yun.Application of SPECT/CT Dual-phase 99mTc-MIBI Tomography in the Diagnosis of Breast Cancer[J].Medical Information,2018,31(06):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
[2]张 虎,张 涛,徐 芳,等.MRI在乳腺癌诊治中的研究进展[J].医学信息,2022,35(10):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
ZHANG Hu,ZHANG Tao,XU Fang,et al.Research Progress of MRI in Diagnosis and Treatment of Breast Cancer[J].Medical Information,2022,35(06):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
[3]李建辉,祝旭龙.乳腺癌的治疗管理——把好生活质量关[J].医学信息,2018,31(13):1.[doi:10.3969/j.issn.1006-1959.2018.13.001]
[4]杨玉峰,李 强,曲国红,等.乳腺癌术前巴德枪穿刺检测ER、PR的临床研究[J].医学信息,2018,31(13):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
YANG Yu-feng,LI Qiang,QU Guo-hong,et al.Clinical Study on Preoperative ER and PR Detection of Bard Gun Puncture in Breast Cancer[J].Medical Information,2018,31(06):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
[5]刘雪静,路 红,徐熠琳,等.乳腺影像与容积导航技术初步应用的临床分析[J].医学信息,2022,35(11):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
LIU Xue-jing,LU Hong,XU Yi-lin,et al.Clinical Analysis of the Preliminary Application of Breast Imaging and Volume Navigation Technology[J].Medical Information,2022,35(06):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
[6]刘在波,修文娟.背阔肌皮瓣联合假体在乳腺癌改良根治术后乳房重建中的应用[J].医学信息,2019,32(02):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
LIU Zai-bo,XIU Wen-juan.Application of Latissimus Dorsi Flap Combined with Prosthesis in Breast Reconstruction after Modified Radical Mastectomy for Breast Cancer[J].Medical Information,2019,32(06):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
[7]孟庆国,王佳雪,王斯佳.马来酸吡咯替尼对乳腺癌术后患者心脏功能的影响[J].医学信息,2019,32(02):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
MENG Qing-guo,WANG Jia-xue,WANG Si-jia.Effect of Pyrrolidine Maleate on Cardiac Function in Patients after Breast Cancer Operation[J].Medical Information,2019,32(06):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
[8]刘 曼,厉玛倩倩,徐润润,等.延续性护理对乳腺癌术后化疗患者生活质量与
健康知识水平的影响[J].医学信息,2018,31(16):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
LIU Man,LIMA Qian-qian,XU Run-run,et al.Effect of Continuous Nursing on Quality of Life and Health Knowledge of Postoperative Chemotherapy Patients with Breast Cancer[J].Medical Information,2018,31(06):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
[9]满枋霖,葛俊宏,林晓月,等.p21活化激酶在乳腺癌中的作用研究[J].医学信息,2019,32(06):35.[doi:10.3969/j.issn.1006-1959.2019.06.013]
MAN Fang-lin,GE Jun-hong,LIN Xiao-yue,et al.The Role of p21 Activated Kinase in Breast Cancer[J].Medical Information,2019,32(06):35.[doi:10.3969/j.issn.1006-1959.2019.06.013]
[10]张天竺,宁 勇.长链非编码RNA调控乳腺癌发生发展的研究进展[J].医学信息,2019,32(12):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]
ZHANG Tian-zhu,NING Yong.Advances in Research on Long-chain Non-coding RNA Regulation of Breast Cancer Development[J].Medical Information,2019,32(06):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]